• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC From PBMC-ALS

  • For research use only

Cat No.

ABC-SC2073

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

PBMC

Disease

Amyotrophic Lateral Sclerosis

Storage

Liquid Nitrogen

Cell Type: iPSC; Primary Tissue: PBMC; Disease: Amyotrophic Lateral Sclerosis(ALS).

Product Image

Description

HighQC™ Human IPSC From PBMC-ALS is a disease-specific human induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) of a donor diagnosed with Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. The cells preserve pluripotency for ALS-related neural mechanism exploration.They retain the fundamental capacity for trilineage differentiation into cell types of all three germ layers—ectoderm, mesoderm, and endoderm. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC From PBMC-ALS, HighQC™ hiPSC ALS PBMC, hiPSC-ALS, HighQC™ Human Induced Pluripotent Stem Cells From Peripheral Blood Mononuclear Cells-Amyotrophic Lateral Sclerosis

Species

Human

Cat.No

ABC-SC2073

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

PBMC

Disease

Amyotrophic Lateral Sclerosis

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human IPSC From PBMC-ALS provides a patient-specific model for studying motor neuron disease. Its pluripotent capacity enables directed differentiation into motor neurons, the primary affected cell type, facilitating research on neurodegeneration mechanisms and disease progression. This system supports the generation of neural organoids for modeling ALS pathology and serves as a platform for high-throughput drug screening to identify potential neuroprotective compounds.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From PBMC-ALS

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button